APAC BIOTECH strives to find roots of cancer - the world's alarming disease, by transforming the promise of technology and knowledge of biology into therapies that have the power to restore health and even save lives of cancer patients.
Dendritic Cells are antigen presenting cells and have high level of major histocompatibility complex, costimulatory molecules and cell adhesion molecules which are essential for antigen presentation.
R & D
APAC BIOTECH carefully designs its' research study projects that determine the effectiveness of the cancer therapy, under the supervision of highly qualified professional investigators.
Apac Biotech has a group of Qualified Researchers and doctors which help in the Research & Development activities. We have a 1000 class clean room facility, with state of art equipment. The driving force behind our research team is to constantly improve the quality sufferers.
To find the roots of cancer andto improve the quality of life by immunology based Dendritic cell based therapy.
Who we are?
APAC Biotech Pvt.Ltd. is a leading biotechnology company which is involved research and manufacturing of Dendritic cell based immunotherapy and preparing the formulation to impede the growth of cancer cells.
Our endeavour is to improve the life expectancy by providing safe and effective dendritic cell based immunotherapy for treatment of cancer patients. Our formulation, APCEDEN® has been developed after a thorough research based on the principles of immunotherapy.
ARUN MEHRA-Chief Executive Officer
Arun Mehra is a visionary entrepreneur, responsible for developing dendritic cell immunotherapy at a commercial scale in India.
Have a question or need to Contact?
Apac Biotech Pvt Ltd.
69, Jacranda Marg , DLF PHASE II. GURGAON, INDIA.
Mob: +91- 9958000827 Tel: 0124-4207575
Website : www.apacbiotech.com